The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (32) Other manufacturing 32.5 - Manufacture of medical and dental instruments and supplies 32.50 - Manufacture of medical and dental instruments and supplies
350 jobs Number of planned job creations
Announcement Date
17 March 2021
Employment effect (start)
17 March 2021
Foreseen end date
Description
The German pharmaceutical group Merck has announced the recruitment of 350 employees, including 80 in 2021, at its site in Molsheim (Bas-Rhin) which specialises in the manufacture of tools for the detection of microbiological pollutants.
The group announces an investment of €25 million to develop the site's production capacity from 2021. The investment will be destined to the creation of a new production unit for 'single-use assemblies', that is watertight bags are used in the manufacturing process of vaccines, such as those currently being developed against COVID-19.
Merck Molsheim employs than 1,700 and it is the group's third largest site worldwide. Currently, the site has three production units representing its three major activities: BioMonitoring, Lab Water Solutions & Instruments, and Systems and Solutions.
Eurofound (2021), Merck, Business expansion in France, factsheet number 104488, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/104488.